{
  "image_filename": "figure_p1_det_0_004.png",
  "image_path": "Zimmerman_et_al.__2023_/extracted/figures/figure_p1_det_0_004.png",
  "image_type": "Figure",
  "page_number": 1,
  "block_id": "det_0_004",
  "claim_id": "claim_003",
  "claim": "Recombinant technology leads to a broader immune response that may provide cross-protection, even in a mismatch season.",
  "supports_claim": false,
  "explanation": "Partial journal page header from the journal Vaccine (Elsevier) showing the article title beginning with 'vaccine effectiveness of recombinant and standard dose influenza vaccines against influenza related hospitalization using a retrospective...'. No figures or data are visible beyond the title and journal branding. does not support the claim because the image only shows the article title and journal header without any data or discussion on immune response breadth, cross-protection, or mismatch season performance. Note: Text is truncated and no study results or figures are visible, limiting the ability to assess any evidence from the article itself.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "Partial journal page header from the journal Vaccine (Elsevier) showing the article title beginning with 'vaccine effectiveness of recombinant and standard dose influenza vaccines against influenza related hospitalization using a retrospective...'. No figures or data are visible beyond the title and journal branding.",
    "evidence_found": null,
    "reasoning": "does not support the claim because the image only shows the article title and journal header without any data or discussion on immune response breadth, cross-protection, or mismatch season performance.",
    "confidence_notes": "Text is truncated and no study results or figures are visible, limiting the ability to assess any evidence from the article itself."
  }
}